| Symbol | NVNO |
|---|---|
| Name | ENVVENO MEDICAL CORP |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 70 DOPPLER, IRVINE, CA 92618 |
| Telephone | 949-261-2900 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001661053 |
| Description | None |
Director Duhay Francis 🔴 sold 140 shares of enVVeno Medical Corp (NVNO) at $10.30 Transaction Date: Jun 11, 2026 | Filing ID: 028426
Read more📋 Duhay Francis (Director) plans to sell 140 shares of enVVeno Medical Corp (at $10.31 each, total $1K) Filed: Jun 11, 2026 | ID: 000375
Read moreenVVeno Medical to Participate in the Virtual Investor Closing Bell Series
Read moreNew Form SCHEDULE 13G/A - enVVeno Medical Corp <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0000919574-26-003332 <b>Size:</b> 20 KB
Read moreenVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment
Read moreenVVeno Medical Discusses FDA IDE Approval in Virtual Investor “What This Means” Segment
Read moreenVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
Read more(70% Positive) ENVVENO MEDICAL CORP (NVNO) Announces Enrollment Update for care Due to Patient Enrollment Issues, Safety Review, Efficacy Assessment
Read moreenVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
Read moreenVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe® System
Read more